|
Part I General Considerations |
|
|
|
Biocompatibility: Definitions and Issues |
|
|
3 | (14) |
|
|
|
3 | (2) |
|
|
|
5 | (1) |
|
|
|
6 | (1) |
|
|
|
7 | (3) |
|
The Discipline of Biomaterials |
|
|
10 | (2) |
|
Afterword: Paradigmatic Shift |
|
|
12 | (5) |
|
|
|
14 | (1) |
|
|
|
15 | (2) |
|
Introduction to the Biological Environment |
|
|
17 | (18) |
|
|
|
17 | (1) |
|
Comparison of External and Internal Conditions |
|
|
17 | (1) |
|
Problems in Definition of the Biological Environment |
|
|
18 | (2) |
|
Elements of the Biological Environment |
|
|
20 | (2) |
|
|
|
22 | (6) |
|
Preimplantation Handling Effects |
|
|
28 | (7) |
|
|
|
29 | (1) |
|
|
|
30 | (5) |
|
Part II Material Response: Function and Degradation of Materials In Vivo |
|
|
|
|
|
35 | (14) |
|
|
|
35 | (1) |
|
|
|
35 | (1) |
|
|
|
36 | (2) |
|
Examples of Undesirable Absorption |
|
|
38 | (4) |
|
|
|
42 | (1) |
|
|
|
43 | (1) |
|
Example of Planned Leaching: Drug Release |
|
|
44 | (2) |
|
Effects of Swelling and Leaching |
|
|
46 | (3) |
|
|
|
46 | (1) |
|
|
|
47 | (2) |
|
Corrosion and Dissolution |
|
|
49 | (24) |
|
|
|
49 | (1) |
|
Classification of Reactions |
|
|
50 | (1) |
|
|
|
51 | (3) |
|
The Electrochemical Series |
|
|
54 | (2) |
|
|
|
56 | (1) |
|
Potential-Current Relationships in Corrosion |
|
|
57 | (1) |
|
|
|
58 | (6) |
|
Corrosion in Implant Applications |
|
|
64 | (2) |
|
Engineering Variables Affecting Corrosion Rates |
|
|
66 | (1) |
|
Corrosion Factors Peculiar to Biological Environments |
|
|
67 | (1) |
|
|
|
68 | (1) |
|
|
|
69 | (1) |
|
|
|
70 | (3) |
|
|
|
70 | (1) |
|
|
|
71 | (2) |
|
Reactions of Biological Molecules with Biomaterial Surfaces |
|
|
73 | (14) |
|
|
|
73 | (1) |
|
|
|
74 | (1) |
|
|
|
74 | (3) |
|
Mechanical Aspects of Interfaces |
|
|
77 | (3) |
|
Results of Interfacial Adhesion of Molecules |
|
|
80 | (2) |
|
Effects of Charged Interfaces and Ions |
|
|
82 | (1) |
|
|
|
83 | (4) |
|
|
|
84 | (1) |
|
|
|
84 | (3) |
|
Mechanics of Materials: Deformation and Failure |
|
|
87 | (20) |
|
|
|
87 | (1) |
|
|
|
87 | (3) |
|
|
|
90 | (6) |
|
|
|
96 | (1) |
|
|
|
97 | (7) |
|
|
|
104 | (3) |
|
|
|
104 | (1) |
|
|
|
105 | (2) |
|
|
|
107 | (18) |
|
|
|
107 | (1) |
|
|
|
107 | (2) |
|
|
|
109 | (5) |
|
|
|
114 | (8) |
|
|
|
122 | (3) |
|
|
|
122 | (1) |
|
|
|
123 | (2) |
|
Interpart 1 Implant Materials: Properties |
|
|
125 | (202) |
|
|
|
125 | (1) |
|
|
|
126 | (3) |
|
|
|
129 | (2) |
|
|
|
131 | (1) |
|
|
|
132 | (7) |
|
|
|
134 | (1) |
|
|
|
135 | (4) |
|
Part III Host Response: Biological Effects of Implants |
|
|
|
|
|
139 | (26) |
|
|
|
139 | (1) |
|
The Inflammatory Response |
|
|
139 | (11) |
|
|
|
150 | (5) |
|
Effects of Implant Degradation Products |
|
|
155 | (5) |
|
|
|
160 | (5) |
|
|
|
160 | (2) |
|
|
|
162 | (3) |
|
Coagulation and Hemolysis |
|
|
165 | (18) |
|
|
|
165 | (1) |
|
|
|
165 | (5) |
|
Approaches to Thromboresistant Materials Development |
|
|
170 | (6) |
|
|
|
176 | (3) |
|
|
|
179 | (4) |
|
|
|
180 | (1) |
|
|
|
181 | (2) |
|
|
|
183 | (20) |
|
|
|
183 | (1) |
|
|
|
183 | (3) |
|
Examples of Adaptation in Implant Applications |
|
|
186 | (11) |
|
A Final Comment on Adaptation |
|
|
197 | (6) |
|
|
|
199 | (2) |
|
|
|
201 | (2) |
|
In Vitro Tissue Growth and Replantation |
|
|
203 | (22) |
|
|
|
203 | (1) |
|
What Is Tissue Engineering? |
|
|
204 | (2) |
|
The Cell-Receptor Paradigm |
|
|
206 | (4) |
|
Matrices and Cell Sources |
|
|
210 | (4) |
|
Thinking Twice about Tissue Engineering |
|
|
214 | (6) |
|
|
|
220 | (5) |
|
|
|
222 | (1) |
|
|
|
223 | (2) |
|
Allergic Foreign Body Response |
|
|
225 | (20) |
|
Specific vs. Nonspecific Response |
|
|
225 | (1) |
|
Mechanisms of Immune Response |
|
|
226 | (4) |
|
Classes of Hypersensitivity Reactions |
|
|
230 | (1) |
|
Hypersensitivity Reactions Associated with Implants |
|
|
230 | (10) |
|
|
|
240 | (5) |
|
|
|
241 | (2) |
|
|
|
243 | (2) |
|
Chemical and Foreign-Body Carcinogenesis |
|
|
245 | (28) |
|
|
|
245 | (1) |
|
|
|
246 | (11) |
|
Foreign Body Carcinogenesis |
|
|
257 | (5) |
|
Nonspecific Carcinogenesis |
|
|
262 | (1) |
|
Evidence for Implant Carcinogenesis in Humans |
|
|
263 | (10) |
|
|
|
268 | (2) |
|
|
|
270 | (3) |
|
|
|
273 | (18) |
|
|
|
273 | (1) |
|
|
|
274 | (9) |
|
|
|
283 | (2) |
|
Human Dietary Metal Intake |
|
|
285 | (6) |
|
|
|
288 | (1) |
|
|
|
289 | (2) |
|
Systemic Distribution and Excretion |
|
|
291 | (26) |
|
|
|
291 | (1) |
|
|
|
291 | (5) |
|
Transport of Dissolved Species |
|
|
296 | (5) |
|
Distribution and Excretion of Dissolved Species |
|
|
301 | (10) |
|
|
|
311 | (6) |
|
|
|
312 | (3) |
|
|
|
315 | (2) |
|
Effects of Degradation Products on Remote Organ Function |
|
|
317 | (10) |
|
|
|
317 | (1) |
|
Examples of Systemic Effects |
|
|
318 | (3) |
|
A Review of Systemic Aspects of Host Response |
|
|
321 | (2) |
|
|
|
323 | (4) |
|
|
|
325 | (1) |
|
|
|
326 | (1) |
|
Interpart 2 Implant Materials: Clinical Performance |
|
|
327 | (132) |
|
|
|
327 | (3) |
|
An Example: Total Hip Replacement |
|
|
330 | (2) |
|
|
|
332 | (5) |
|
|
|
332 | (1) |
|
|
|
333 | (4) |
|
Part IV Methods of Testing for Biological Performance |
|
|
|
|
|
337 | (18) |
|
|
|
337 | (1) |
|
|
|
338 | (1) |
|
|
|
338 | (9) |
|
|
|
347 | (3) |
|
|
|
350 | (5) |
|
|
|
351 | (2) |
|
|
|
353 | (2) |
|
|
|
355 | (28) |
|
|
|
355 | (3) |
|
|
|
358 | (12) |
|
|
|
370 | (13) |
|
|
|
370 | (3) |
|
|
|
373 | (1) |
|
|
|
374 | (9) |
|
Clinical Testing of Implant Materials |
|
|
383 | (20) |
|
|
|
383 | (1) |
|
Design of Clinical Trials |
|
|
384 | (8) |
|
Conclusions from Clinical Trials |
|
|
392 | (2) |
|
Aspects of the Decision for General Clinical Use |
|
|
394 | (4) |
|
|
|
398 | (5) |
|
|
|
400 | (1) |
|
|
|
401 | (2) |
|
Standardization and Regulation of Implant Materials |
|
|
403 | (24) |
|
|
|
403 | (1) |
|
Drug Standardization Activities |
|
|
404 | (2) |
|
Biomaterials Standardization Activities |
|
|
406 | (9) |
|
U.S. Federal Regulation of Medical Devices and Biomaterials |
|
|
415 | (4) |
|
Regulation of Materials for Implants |
|
|
419 | (3) |
|
The Biomaterials Supply ``Crisis'' |
|
|
422 | (5) |
|
|
|
423 | (1) |
|
|
|
424 | (3) |
|
Design and Selection of Implant Materials |
|
|
427 | (14) |
|
|
|
427 | (2) |
|
|
|
429 | (9) |
|
The Value of Prospective Design |
|
|
438 | (3) |
|
|
|
439 | (1) |
|
|
|
440 | (1) |
|
Clinical Performance of Biomaterials |
|
|
441 | (18) |
|
|
|
441 | (2) |
|
Procedures for Device Retrieval and Analysis |
|
|
443 | (4) |
|
Common Concerns about Device Retrieval and Analysis |
|
|
447 | (3) |
|
Proposed National Implant Data Retrieval and Analysis Program (NIDRA) |
|
|
450 | (1) |
|
Elements of a NIDRA System |
|
|
451 | (4) |
|
Autopsy Retrieval Studies |
|
|
455 | (1) |
|
|
|
456 | (3) |
|
|
|
457 | (1) |
|
|
|
457 | (2) |
|
|
|
459 | (12) |
|
|
|
459 | (1) |
|
|
|
460 | (9) |
|
|
|
469 | (2) |
|
|
|
470 | (1) |
| Index |
|
471 | |